DelveInsight's Hereditary Transthyretin Amyloidosis Market Insights report includes a comprehensive understanding of current ...

A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...

Swelling, or edema, is more than just a nuisance—it can feel like carrying extra baggage in your legs, ankles, or abdomen.  For those living with ATTR-CM (transthyretin amyloid cardiomyopathy), a rare ...

However, its projections look too optimistic, and the stock carries considerable risk. 10 stocks we like better than Intellia ...

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Heart failure now accounts for 45% of cardiovascular deaths and approximately one-quarter of Americans will have it in their ...

As the industry loses one of its key female leaders in GSK CEO Emma Walmsley, BioSpace profiles the women leading the ...

Our RNAi play came from the understanding that personalization and the development of curated therapies are the future of ...

Nature put on her best show at Two Mile Run County Park Monday afternoon as hundreds of people drove through the sunshine and changing fall colors to the Nature Lodge ...

The Broncos turned into a GM factory under Elway, as four current and two former GMs were in Denver under his Super ...

An updated report on statistics regarding heart failure epidemiology and outcomes has been published by the HFSA.